Related Experiment Video

Updated: Jul 23, 2026

A Rapidly Incremented Tethered-Swimming Maximal Protocol for Cardiorespiratory Assessment of Swimmers
09:24

A Rapidly Incremented Tethered-Swimming Maximal Protocol for Cardiorespiratory Assessment of Swimmers

Published on: January 28, 2020

9.5K

Transatlantic Comparison of ST-Segment Elevation Myocardial Infarction Guidelines: Insights From the United States

Kevin R Bainey1, Paul W Armstrong1

  • 1Canadian VIGOUR Centre, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.

Journal of the American College of Cardiology
|January 3, 2016
PubMed

Insights

Guidelines for ST-segment elevation myocardial infarction (STEMI) care from Europe and the US were updated in 2012-2013. This review compares these transatlantic guidelines, noting key differences in STEMI management recommendations.

Area of Science:

  • Cardiology
  • Clinical Practice Guidelines

Background:

  • ST-segment elevation myocardial infarction (STEMI) is a critical global health issue.
  • Evidence-based practice guidelines are essential for optimal STEMI patient care.
  • Therapeutic advancements necessitate frequent guideline updates.

Purpose of the Study:

  • To compare the 2012 European Society of Cardiology guidelines with the 2013 American College of Cardiology Foundation/American Heart Association guidelines for STEMI management.
  • To identify and highlight key differences in recommendations and evidence interpretation between the transatlantic guidelines.

Main Methods:

  • Comparative analysis of the European Society of Cardiology (2012) and American College of Cardiology Foundation/American Heart Association (2013) guidelines for STEMI.
  • Review of guideline recommendations and the underlying evidence base for STEMI care.

Main Results:

  • The review identifies specific differences in STEMI management strategies between European and US guidelines.
  • Discrepancies in the interpretation of evidence for STEMI treatment are highlighted.

Conclusions:

  • Regular comparison of international guidelines is crucial for advancing STEMI care.
  • Understanding transatlantic differences can inform clinical practice and future guideline development for myocardial infarction.

Keywords:
acute coronary syndromeanticoagulantsfibrinolytic therapyischemic timepercutaneous coronary interventionstandard of care

More Related Videos

Mesoscopic Optical Imaging of Whole Mouse Heart08:53

Mesoscopic Optical Imaging of Whole Mouse Heart

Published on: October 14, 2021

2.8K
Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

2.0K

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...